Revalesio Corporation is a pioneering biotechnology company based in Tacoma, Washington, dedicated to restoring hope and transforming lives.

Our goal is to maximize the benefits of our novel technology by developing products that represent a potential new class of treatments for inflammatory mediated diseases. To that end, Revalesio has partnered with leaders in biomedical research as well as non-profit organizations around the world, to help us deliver on our promise to bring hope to people around the globe.